The historically mixed data and the need to control for confounding required further investigation into the association between use of progestogen‑only injectables and increased risk of HIV acquisition, using a more robust research design. This led to the development of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial.
The results of the ECHO trial were published in the Lancet on 13 June 2019. The ECHO trial finds no link between HIV acquisition and the use of DMPA-IM, progestogen implant, and non-hormonal copper IUD.
Emergency contraception is a safe and effective method for preventing unwanted pregnancy and can reduce the risk of pregnancy by up to 99%. Yet, in many countries, women face barriers to accessing it. The majority of women in low‑income countries are unaware of EC. Moreover, some providers have negative attitudes toward providing EC to women and girls
The Global Financing Facility (GFF) is a financing mechanism in support of reproductive, maternal, newborn, child and adolescent health launched in 2015. This IPPF briefing sets out recommendations for GFF stakeholders and financiers as the GFF undergoes its first replenishment process.
The Association Burundaise pour le Bien-Etre Familial's (ABUBEF) provides vital integrated services to local communities, including contraception, prevention and treatment of HIV.The Global Gag Rule (GGR) threatens their very existence and are set to lose 39% of their funding.